Wall street

Market Commentary September 2020

The Market Commentary includes a brief summary of key markets, asset classes and our outlook. We…

Back to work

Back to work as restrictions lift

During the last two weeks there have been a considerable number of companies reporting which has…

Covid-19 clusters anticipated – but moving to re-open economies

The viral infections now seem to be appearing as spot clusters and seem to be following an…

Covid 19

Virus Flattened? Now Economies Need to Re-Start

The problem now is how quickly economies can be opened-up again, ending the damage being done to…

Covid 19 Markets

PPM Insights: COVID-19 Implications by Industry

From an economic point of view the length of time that isolation measures need to remain in place…

March Covid-19

End of March COVID-19 Update

Additional update in relation to the COVID-19 pandemic and implications for both the domestic and…

COVID-19

COVID-19 Update

The spread of the COVID-19 virus has increased in Europe and the US and it is presumed in emerging…

Brexit

Insights into Brexit

PPM, recently had the opportunity to speak to The Honourable Alexander Downer, AC to discuss his…

Life Science

Life Science: Inside four Australian and New Zealand companies that are changing the biotech landscape

The success of life science companies CSL, Resmed and Cochlear are well known and they are now…

Telstra in tangles

Telstra in Tangles?

You may be aware of the recent press and broker commentary on Telstra, which has been universally…

PPM is a boutique investment manager focused on generating superior long-term, tax effective returns.

CONTACT US

The rating contained in this document is issued by SQM Research Pty Ltd ABN 93 122 592 036 AFSL 421913. SQM Research is an investment research firm that undertakes research on investment products exclusively for its wholesale clients, utilising a proprietary review and star rating system. The SQM Research star rating system is of a general nature and does not take into account the particular circumstances or needs of any specific person. The rating may be subject to change at any time. Only licensed financial advisers may use the SQM Research star rating system in determining whether an investment is appropriate to a person’s particular circumstances or needs. You should read the product disclosure statement and consult a licensed financial adviser before making an investment decision in relation to this investment product. SQM Research receives a fee from the Fund Manager for the research and rating of the managed investment scheme.

Close*Research Ratings Disclaimer